Ontrak (NASDAQ:OTRK) vs. Daxor (NASDAQ:DXR) Head-To-Head Survey

Daxor (NASDAQ:DXR) and Ontrak (NASDAQ:OTRK) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

Institutional & Insider Ownership

1.3% of Daxor shares are owned by institutional investors. Comparatively, 12.9% of Ontrak shares are owned by institutional investors. 59.5% of Daxor shares are owned by insiders. Comparatively, 1.9% of Ontrak shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Daxor and Ontrak, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Daxor	0	0	1	0	3.00
Ontrak	0	0	1	0	3.00

Daxor currently has a consensus price target of $25.00, suggesting a potential upside of 114.41%. Ontrak has a consensus price target of $3.00, suggesting a potential upside of 13,821.11%. Given Ontrak’s higher probable upside, analysts plainly believe Ontrak is more favorable than Daxor.

Volatility & Risk

Daxor has a beta of -0.1, suggesting that its share price is 110% less volatile than the S&P 500. Comparatively, Ontrak has a beta of 1.97, suggesting that its share price is 97% more volatile than the S&P 500.

Profitability

This table compares Daxor and Ontrak’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Daxor	N/A	N/A	N/A
Ontrak	-274.20%	-269.88%	-128.35%

Valuation and Earnings

This table compares Daxor and Ontrak”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Daxor	N/A	N/A	N/A	N/A	N/A
Ontrak	$10.18 million	0.01	-$25.49 million	($15.81)	0.00

Daxor has higher earnings, but lower revenue than Ontrak.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

About Ontrak

Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.